"Gene mutations lead to inability to feel pain"
(last accessed 2/2008)
(Dec 13) Reuters Health via Iconocast reports, “A rare inability to perceive pain, which has only been described in a handful of individuals, results from mutations in a specific gene, new research shows. The researchers hope that the findings could lead to new and safer painkillers.”
“Nine new genes discovered”
(Dec 13) People’s Daily Online reports, “The Blood Center in Henan province, has announced that the nine new human HLA alleles which it identified have been approved the World Health Organization (WHO) and the name officially adopted.”
“Leicester breakthrough in eye disease”
(Dec 13) EurekAlert! reports, “Researchers at the University of Leicester have identified for the first time a gene which causes a distressing eye condition.”
“Unfolding The Genetic Code”
(Dec 12) Medical News Today reports, “It turns out that sequencing the human genome - determining the order of DNA building blocks -- has not completely cracked the code of how DNA directs various cellular processes.”
“Searching for Disease Genes Gets Easier”
(Dec 11) Technology Review reports, “Over the next year, scientists expect to uncover genetic secrets of such complex diseases as diabetes, heart disease, and autism.”
“Gene therapy—fiction or reality?”
(Dec 11) Express Pharma reports, “They are the basis of life and hold the keys to unlock the code to counter genetic diseases.”
“Gene Mutation Predicts Outcome In Blood Disorder”
(Dec 11) Medical News Today reports, “Both the cause and cure for polycythemia vera, a disorder of uncontrolled blood cell production, remain elusive, but researchers from the University of Florence, Italy, may be a step closer to both.”
“Gene Mutations Predict Treatment Outcomes In Patients With Leukemia”
(Dec 11) Medical News Today reports, “Curing acute myeloid leukemia (AML), a rapidly progressing bone-marrow cancer, is possible, but only in about 20-30 percent of patients, depending on a number of prognostic factors.”
“AVN944 inhibits IMPDH & induces apoptosis-related biomarkers in patients with hematologic
cancers”
(Dec 11) EurekAlert! reports, “Avalon Pharmaceuticals, Inc., presented a poster detailing the effect of AVN944 on a comprehensive set of genetic and biochemical biomarkers at the American Society of Hematology 48th Annual Meeting.”
“Genetic map offers new tool for malaria research”
(Dec 10) EurekAlert! reports, “An international research team announced today the completion of a genome-wide map that charts the genetic variability of the human malaria parasite Plasmodium falciparum.”
“Inheritance outside DNA”
(last accessed 2/2008)
(Dec 10) EurekAlert! reports, “Most people have heard that human inheritance is spelled out in our DNA and activated through our genes.”
“Cancer immunoresistance linked to loss of tumor suppressor gene”
(Dec 10) EurekAlert! reports, “Cancer immunoresistance may be partially due to loss of a well-known tumor suppressor gene, according to new research led by Andrew T. Parsa, MD, PhD, assistant professor of neurological surgery at the University of California, San Francisco.”
“Researchers Developing Molecular Delivery Vehicles For Genetic Therapies”
(Dec 10) Science Daily reports, “Researchers at New York University are working to develop molecular delivery vehicles that can be used to transport nucleic acids into diverse cell types, which may lead to eventual applications in genetic therapies.”
“Mayo Clinic Cancer Center -- individualizing treatment for multiple myeloma patients”
(Dec 10) EurekAlert! reports, “Researchers at Mayo Clinic Cancer Center, in cooperation with industry partners, have, for the first time, identified tumor specific alterations in the cellular pathway by which the multiple myeloma drug bortezomib (Velcade) works, and they have identified nine new genetic mutations in cancer cells that should increase a patient's chance of responding to the agent.”
“Quebecers said perfect gene pool for medical research”
(Dec 8) Reuters Health reports, “Quebecers, many of them descended from a handful of families who arrived from France, could hold the key to medical breakthroughs as their tiny gene pool provides the perfect testing ground for researchers and pharmaceutical firms.”
“'Best of both worlds' -- Targeting a single gene could inhibit bone decay and stimulate bone
growth”
(Dec 8) EurekAlert! reports, “Researchers at the University of Pennsylvania’s School of Medicine have found by targeting the function of a single gene that it is possible to inhibit bone decay while simultaneously stimulating bone formation.”
|